Belite Bio (BLTE) Short Interest Ratio & Short Volume → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free BLTE Stock Alerts $48.95 +0.20 (+0.41%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Belite Bio Short Interest DataCurrent Short Interest35,400 sharesPrevious Short Interest18,900 sharesChange Vs. Previous Month+87.30%Dollar Volume Sold Short$1.50 millionShort Interest Ratio0.9 Days to CoverLast Record DateMay 15, 2024Outstanding Shares29,790,000 sharesPercentage of Shares Shorted0.12%Today's Trading Volume19,495 sharesAverage Trading Volume49,818 sharesToday's Volume Vs. Average39% Short Selling Belite Bio ? Sign up to receive the latest short interest report for Belite Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBLTE Short Interest Over TimeBLTE Days to Cover Over TimeBLTE Percentage of Float Shorted Over Time Ad Paradigm PressDems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. Belite Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202435,400 shares $1.50 million +87.3%N/A0.9 $42.45 4/30/202418,900 shares $767,340.00 -44.4%N/A0.5 $40.60 4/15/202434,000 shares $1.24 million -13.0%N/A0.7 $36.40 3/31/202439,100 shares $1.50 million -34.3%N/A0.6 $38.37 3/15/202459,500 shares $2.29 million +20.7%N/A0.8 $38.47 2/29/202449,300 shares $2.28 million +4.5%N/A0.6 $46.25 Get the Latest News and Ratings for BLTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Belite Bio and its competitors with MarketBeat's FREE daily newsletter. 2/15/202447,200 shares $2.27 million -11.3%N/A0.5 $48.00 1/31/202453,200 shares $2.31 million -6.0%N/A0.5 $43.43 1/15/202456,600 shares $2.59 million +40.8%N/A0.4 $45.81 12/31/202340,200 shares $1.84 million -47.9%N/A0.3 $45.75 12/15/202377,100 shares $3.46 million +19.5%N/A0.6 $44.83 11/30/202364,500 shares $2.71 million -26.3%N/A0.5 $42.07 11/15/202387,500 shares $3.24 million -9.7%N/A0.7 $37.02 10/31/202396,900 shares $3.63 million +172.2%N/A0.8 $37.51 10/15/202335,600 shares $1.14 million -5.3%N/A0.4 $32.00 9/30/202337,600 shares $1.20 million -14.9%N/A0.5 $31.85 9/15/202344,200 shares $1.42 million +17.9%N/A0.5 $32.20 8/31/202337,500 shares $1.29 million +7.1%N/A0.5 $34.35 8/15/202335,000 shares $775,950.00 -24.1%N/A0.5 $22.17 7/31/202346,100 shares $1.07 million +30.6%N/A0.8 $23.22 7/15/202335,300 shares $474,432.00 -26.6%N/A0.7 $13.44 6/30/202348,100 shares $678,691.00 +13.7%N/A1.4 $14.11 6/15/202342,300 shares $607,005.00 +60.8%N/A1.4 $14.35 5/31/202326,300 shares $433,687.00 -3.3%N/A1 $16.49 5/15/202327,200 shares $639,200.00 -18.6%N/A2.3 $23.50 4/30/202333,400 shares $966,262.00 +5.4%N/A3.1 $28.93 4/15/202331,700 shares $911,375.00 +13.6%N/A3 $28.75 3/31/202327,900 shares $834,207.21 -24.4%N/A2.7 $29.90 3/15/202336,900 shares $1.13 million -4.9%N/A3.2 $30.50 2/28/202338,800 shares $1.28 million +1.8%N/A3.6 $33.10 2/15/202338,100 shares $1.22 million -8.9%N/A3 $32.00 1/31/202341,800 shares $1.25 million -52.8%N/A3.2 $29.89 1/15/202388,600 shares $2.53 million -12.1%N/A4.9 $28.50 12/30/2022100,800 shares $3.04 million -1.4%N/A4.8 $30.15 12/15/2022102,200 shares $3.04 million -13.2%N/A3.9 $29.73 11/30/2022117,800 shares $3.86 million -8.8%N/A4.1 $32.77 11/15/2022129,200 shares $3.24 million -5.3%N/A3.9 $25.10 10/31/2022136,400 shares $3.97 million +5.1%N/A3.3 $29.07 10/15/2022129,800 shares $3.60 million +3.8%N/A2.9 $27.77 9/30/2022125,100 shares $4.20 million -11.3%N/A2.1 $33.55[Urgent!] Generational Wealth Gameplan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide 9/15/2022141,100 shares $5.02 million -5.5%N/A2 $35.55 8/31/2022149,300 shares $4.79 million +30.1%N/A1.7 $32.11 8/15/2022114,800 shares $3.50 million +14.1%N/A1.4 $30.50 7/31/2022100,600 shares $3.38 million -9.2%N/A1 $33.60 7/15/2022110,800 shares $4.66 million No ChangeN/A0.3 $42.07 BLTE Short Interest - Frequently Asked Questions What is Belite Bio's current short interest? Short interest is the volume of Belite Bio shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 35,400 shares of BLTE short. Learn More on Belite Bio's current short interest. What is a good short interest ratio for Belite Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BLTE shares currently have a short interest ratio of 1.0. Learn More on Belite Bio's short interest ratio. Is Belite Bio's short interest increasing or decreasing? Belite Bio saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 35,400 shares, an increase of 87.3% from the previous total of 18,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Belite Bio's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Belite Bio: Organon & Co. (3.16%), BridgeBio Pharma, Inc. (11.26%), Grifols, S.A. (3.10%), Cytokinetics, Incorporated (14.05%), Apellis Pharmaceuticals, Inc. (10.37%), Madrigal Pharmaceuticals, Inc. (19.57%), Alpine Immune Sciences, Inc. (5.67%), Nuvalent, Inc. (20.34%), Alkermes plc (7.65%), Perrigo Company plc (3.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Belite Bio stock? Short selling BLTE is an investing strategy that aims to generate trading profit from Belite Bio as its price is falling. BLTE shares are trading up $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Belite Bio? A short squeeze for Belite Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BLTE, which in turn drives the price of the stock up even further. How often is Belite Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLTE, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Organon & Co. Short Interest BridgeBio Pharma Short Interest Grifols Short Interest Cytokinetics Short Interest Apellis Pharmaceuticals Short Interest Madrigal Pharmaceuticals Short Interest Alpine Immune Sciences Short Interest Nuvalent Short Interest Alkermes Short Interest Perrigo Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BLTE) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belite Bio, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.